Channel Avatar

ERN ReCONNET @UCp5IRtsp82c4D2uJ1PRFQ-g@youtube.com

1.52K subscribers - no pronouns set

Welcome to the ERN ReCONNET official YouTube channel! Here


46:33
Preconception Care in Patients with Connective Tissue Diseases
01:57:20
ERN ReCONNET GOOD PRACTICE SHARING INITIATIVE 2024 - 2nd Edition
01:02:14
Everything you always wanted to know about Ehlers-Danlos Syndrome (EDS)
56:07
Update on Hypermobile type of Ehlers-Danlos Syndromes (EDS).
48:01
2023 ACR/EULAR AntiPhospholipid Syndrome (APS) classification criteria
01:01:06
French practical guidelines for the diagnosis and management of Relapsing Polychondritis (RP)
36:07
Unravelling 50 years of Mixed Connective tissue Disease (MCTD)
06:35
ERN ReCONNET Webinar Calendar 2023 - 2024
41:37
Juvenile Onset Systemic Sclerosis: Insights on an Orphan Disease
51:36
10 questions in Relapsing Polychondritis (RP)
05:02
ERN RECONNET – ENDORSED EVENT: 43RD EUROPEAN WORKSHOP FOR RHEUMATOLOGY RESEARCH (IT)
05:01
ERN RECONNET – ENDORSED EVENT: 43RD EUROPEAN WORKSHOP FOR RHEUMATOLOGY RESEARCH (EN)
01:14
ERN RECONNET – ENDORSED EVENT: II XUEC CONFERENCE ON SYSTEMIC AUTOIMMUNE MINORITARY DISEASES (EN)
01:35
ERN RECONNET – ENDORSED EVENT: II XUEC CONFERENCE ON SYSTEMIC AUTOIMMUNE MINORITARY DISEASES (Cat.)
58:30
Young people with childhood Lupus: do they need a different approach in adult life?
02:17
ERN RECONNET – ENDORSED EVENT: THE 5TH INTERNATIONAL SYMPOSIUM ON IGG4 – RELATED DISEASE (IT)
02:05
ERN RECONNET – ENDORSED EVENT: THE 5TH INTERNATIONAL SYMPOSIUM ON IGG4 – RELATED DISEASE (EN)
48:22
Characterization of pain in connective tissue diseases and its management. Everyone's problem.
48:56
Refractory Systemic Lupus Erythematous (SLE): Identification and pharmacological management
33:17
Anti-nuclear antibodies: Practical tips on when, why and how
41:52
Treatment options in Idiopathic Inflammatory Myopathies (IIMs)
02:17
ERN ReCONNET @ EULAR2023: ePAG's Coraline Bouillot opinion (FRENCH)
55:21
Systemic sclerosis (SSc) patients and doctors: A win win alliance
01:35
ERN ReCONNET Clinical Patient Management System (CPMS) in French
50:21
The multifaceted aspects of nutrition
01:55
ERN ReCONNET endorsed Congress: Prof. Lorenzo Cavagna's opinion (French)
01:58
ERN ReCONNET endorsed Congress: Prof. Lorenzo Cavagna's opinion (English)
02:41
ERN ReCONNET endorsed Congress: Prof. Lorenzo Cavagna's opinion (Italian)
34:29
Spectrum of skin manifestations in dermatomyositis
03:07
ERN ReCONNET @ EULAR2023: ePAG's Silvia Aguilera opinion
02:39
ERN ReCONNET @ EULAR2023: ePAG's Coraline Bouillot opinion (ENGLISH)
01:00:58
VEXAS and Relapsing Polychondritis (RP)
57:14
Discordance between patients and clinicians and health related quality of life
42:11
Joint hypermobility in Children: how to approach, how to diagnose
47:31
The oral component of Sjögren’s disease
59:05
Sjögren’s essentials
01:15
TogethERN ReCONNET Registry
49:35
Inflammatory Myopathies and physical/social and working activities
51:57
Introduction to Relapsing Polychondritis (RP) and how to explain RP to my family and friends
44:45
How to explain Undifferentiated connective tissue disease (UCTD) to my family and friends
01:00:21
Pregnancy and Antiphospholipid syndrome (APS)
46:43
Diagnosis and classification of Systemic sclerosis (SSc). Present and future challenges.
01:01:35
Introduction to different subtypes of Idiopathic inflammatory myopathies (IIMs)
31:02
What are the pitfalls and red flags of Relapsing Polychondritis (RP) to be considered by the GP/HCP?
54:51
What is Antiphospholipid syndrome (APS)? How can I explain it to my family and friends?
30:41
Mixed connective tissue disease (MCTD): A 2023 update
01:59:29
ERN ReCONNET Good Practice Sharing Initiative 2023 - 1st Edition
01:58
ERN ReCONNET @ EULAR2023: Dr Massimo Radin's opinion
02:08
ERN ReCONNET @ EULAR2023: Dr Chiara Cardamone's opinion
57:49
IgG4 related disease: A patient experience
01:24:10
EULAR 2023 Debrief – for people living with lupus
48:01
How can I improve my adherence to treatment?
42:09
Coping with Mixed connective tissue disease (MCTD)
01:00:53
How we treat challenging cases of Antiphospholipid syndrome (APS)
54:46
Newer treatments in Systemic Lupus Erythematosus (SLE)
55:42
IgG4 related disease a challenge in the diagnosis
59:58
What do we know about Fatigue in systemic lupus, a LEAF evidence-based update
19:40
Treatment of thrombotic Antiphospholipid Syndrome (APS)
30:28
Adherence to treatment in connective tissue diseases: A multi-faceted issue
27:11
Health System Resilience in rare and complex diseases context: Looking for the determinants